Form 4: Caribou Biosciences Chief Medical Officer Receives Stock Options and Restricted Stock Units

Tina M. Albertson, Chief Medical Officer of Caribou Biosciences, Inc., reports the acquisition of stock options and restricted stock units.

Summary

• Tina M. Albertson, the Chief Medical Officer of Caribou Biosciences, Inc., filed a Form 4 on February 21, 2025, reporting changes in beneficial ownership.
• On February 20, 2025, Albertson acquired 14,589 shares of common stock in the form of restricted stock units (RSUs).
• These RSUs vest in four equal annual installments starting February 20, 2026, contingent upon continued service to the Issuer.
• The RSUs will be settled in stock within 30 days after each vesting date.
• Albertson also acquired an option to purchase 66,137 shares of common stock at an exercise price of $1.41.
• 25% of these options vest on February 20, 2026, with the remaining options vesting monthly over the subsequent 36 months, also contingent upon continued service.
• Following these transactions, Albertson directly owns 14,589 shares of common stock and options to purchase 66,137 shares of common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The granting of equity-based compensation is a common practice and generally viewed favorably as it aligns management's interests with shareholders.

Positives

• The grant of RSUs and stock options to the Chief Medical Officer aligns her interests with those of the shareholders.
• The vesting schedules incentivize continued service and contribution to the company's success.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedules of the RSUs and stock options.

Industry Context

Stock option and RSU grants are common compensation practices for executives in biotech companies, aligning their interests with shareholders and incentivizing long-term performance.

Stakeholder Impact

• Shareholders may view the equity grants positively as they incentivize management to increase shareholder value.
• Employees may see this as a positive sign of the company's commitment to its leadership.

Key Dates

Keywords

Caribou Biosciences, CRBU, Form 4, Beneficial Ownership, Tina M. Albertson, Chief Medical Officer, Restricted Stock Units, Stock Options, Vesting